GlassScriptPhysician profile
Mayleen Soto
NPI 1053818054
$2,270.14
in general payments reported to CMS, 2019-2025
17 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $485 · 2023: $591 · 2024: $499 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $467.96 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $451.35 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $346.10 | 2022-2025 | |
| Amgen INC. | $261.26 | 2022-2025 | Prolia, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $256.15 | 2023-2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $88.32 | 2024-2025 | Cologuard Collection Kit |
| Intercept Pharmaceuticals, INC. | $81.53 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $68.98 | 2023-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $61.71 | 2025 | |
| Astellas Pharma US INC | $39.02 | 2024-2025 | Veozah |
| Pfizer INC. | $31.64 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.93 | 2025 | Gattex |
| Verona Pharma, INC. | $23.08 | 2025 | Ohtuvayre |
| Sumitomo Pharma America, INC. | $20.46 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $17.81 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.89 | 2023 | Xarelto |
| Electromed, INC. | $12.95 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayleen Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.